NEW YORK (GenomeWeb News) – The University of Edinburgh has entered into a collaboration with the IBM Watson Research Center and the National Physical Laboratory, in Middlesex, to use supercomputers to study surface proteins of HIV-1 with the goal of developing drugs that inhibit HIV infection.
 
The University of Edinburgh said yesterday that knowing the structure and behavior of certain peptides will allow researchers to develop drugs that target the infection process.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.